Eledon pharmaceuticals to present at two investor conferences in september

Irvine, calif., sept. 01, 2021 (globe newswire) -- eledon pharmaceuticals, inc. (“eledon”) (nasdaq: eldn), a clinical stage biopharmaceutical company focused on developing targeted medicines for persons living with autoimmune disease, requiring an organ or cell-based transplant, or living with amyotrophic lateral sclerosis (als), today announced that management will present a corporate overview and participate in one-on-one investor meetings at the hc wainwright 23rd annual global investment conference. the company's presentation will be available on-demand beginning on monday, september 13 at 7:00am est.
ELDN Ratings Summary
ELDN Quant Ranking